Efficacy And Safety Of Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler (GFF MDI) Formulated Using Co-Suspension Delivery Technology In Chinese Patients With COPD

BACKGROUND: Glycopyrrolate/formoterol fumarate metered dose inhaler (GFF MDI) is a long-acting muscarinic antagonist/long-acting β(2)-agonist fixed-dose combination therapy delivered by MDI, formulated using innovative co-suspension delivery technology. The PINNACLE-4 study evaluated the efficacy an...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Rongchang, Zhong, Nanshan, Wang, Hao-Yan, Zhao, Li, Mei, Xiaodong, Qin, Zhiqiang, Huang, Juan, Assam, Pryseley N, Maes, Andrea, Siddiqui, Shahid, Martin, Ubaldo J, Reisner, Colin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6956867/
https://www.ncbi.nlm.nih.gov/pubmed/32021143
http://dx.doi.org/10.2147/COPD.S223638

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6956867/
https://www.ncbi.nlm.nih.gov/pubmed/32021143
http://dx.doi.org/10.2147/COPD.S223638

Ejemplares similares